AbelZeta

AbelZeta Pharma is a global, clinical-stage biopharmaceutical company focused on developing innovative and proprietary cell-based therapeutic products. They have centers of excellence in Rockville, Maryland and Shanghai, China. Their mission is to develop and bring to market immune cell therapies for the treatment of cancerous diseases and serious inflammatory and immunological conditions. Their core strengths include their proven target and optimal design in the development of their pipeline assets, their exceptional early clinical results, partnered lead programs with global pharma for hematological cancer and solid tumors, and a platform potential to facilitate the development of multiple cell therapies.

AbelZeta Pharma is actively involved in clinical trials, currently performing investigations of novel CAR-T and TIL therapies in multiple disease areas including hematological malignancies, solid tumors and inflammatory and immunological diseases. They have numerous ongoing clinical trials and have announced promising clinical data for C-CAR031, an armored autologous GPC3 CAR-T for patients with advanced hepatocellular carcinoma. They also have partnerships with multinational pharmaceutical companies to facilitate the commercialization of their products to maximize worldwide patient accessibility.

AbelZeta offers a competitive benefits package to care for its employees' health and well-being. The specific benefits offered are not detailed on the website, but it is emphasized that the company strongly supports its staff and promotes their well-being.

AbelZeta Pharma is a global clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for cancer, inflammatory, and immunological diseases. Their mission is to leverage their proprietary T-cell-based therapeutics to create bespoke treatments that harness the body's own immune system to fight these diseases. They partner with and license to multinational pharmaceutical companies to ensure their products reach patients worldwide, striving to make a tangible difference in the lives of those affected by these conditions.

AbelZeta promotes a culture that values integrity, teamwork, and urgency in developing new medicines for patients. The company prioritizes diversity, inclusion, and collaboration, creating a positive and supportive work environment. The leadership team focuses on innovation, development, and employee well-being, fostering a sense of pride and commitment among its staff.

AbelZeta is committed to creating a diverse and inclusive workplace where all employees are respected and valued. They emphasize diversity, inclusion, and collaboration in their company culture, creating a positive and supportive work environment. The leadership team focuses on innovation, development, and employee well-being.